NCT07101159 2025-08-03
Dalpiciclib as Adjuvant Therapy for HR-positive/HER2-negative Early-stage Patients
Fujian Cancer Hospital
Phase 2 Not yet recruiting
Fujian Cancer Hospital
Instituto Jalisciense de Cancerologia
Instituto Nacional de Cancer, Brazil
Dharmais National Cancer Center Hospital